[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.241.199. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,340
Citations 0
Editorial
August 2016

Cancer Center Advertising—Where Hope Meets Hype

Author Affiliations
  • 1Center for Medicine and the Media, Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire
  • 2Dartmouth-Hitchcock, Lebanon, New Hampshire
JAMA Intern Med. 2016;176(8):1068-1070. doi:10.1001/jamainternmed.2016.3278

Cancer centers advertise to reach patients and their families in a very competitive market. Patients often have dangerous cancers and face toxic treatments and the advertisements offer hope. But the hope can—and often does—morph into hype. After all, this is advertising. Medicine has long been ambivalent about advertising services. The AMA’s original code of ethics1 banned advertising as “derogatory to the profession” and “reprehensible” until forced to relent by federal courts in 1980.2 However, as Vater et al3 show in this issue of JAMA Internal Medicine, the marketing of cancer services is growing. An essential question is how to ensure that advertisements do not take advantage of vulnerable patients.

First Page Preview View Large
First page PDF preview
First page PDF preview
×